Gain expert insights into the potential impact of major changes to reimbursement and regulations.Read More »
Gain insights into CMS' proposals for the 340B drug discount program.Read More »
Revenue integrity professionals came together for two days of empowering learning and networking at the 2025 Revenue Integrity Symposium (RIS).Read More »
Understand the implications of the potential elimination of the inpatient-only (IPO) list.Read More »
Put your commitment to excellence into action.Read More »
Learn about new requirements and reimbursement changes.Read More »
Learn about potential changes to MS-DRGs in the 2026 Outpatient Prospective Payment System proposed rule.Read More »
One of the most common errors seen in skin substitute claims is the inappropriate application of drug waste modifiers, which are as follows:
